Livzon Pharmaceutical Group Inc. (SHE:000513)

China flag China · Delayed Price · Currency is CNY
41.55
+0.78 (1.91%)
Sep 5, 2025, 2:45 PM CST
1.91%
Market Cap34.98B
Revenue (ttm)11.80B
Net Income (ttm)2.17B
Shares Out890.38M
EPS (ttm)2.39
PE Ratio17.39
Forward PE16.64
Dividend1.10 (2.64%)
Ex-Dividend DateJun 13, 2025
Volume7,817,490
Average Volume12,524,203
Open40.00
Previous Close40.77
Day's Range40.00 - 41.67
52-Week Range32.94 - 44.87
Beta0.27
RSI54.06
Earnings DateAug 21, 2025

About SHE:000513

Livzon Pharmaceutical Group Inc. researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People’s Republic of China. The company offers Ilaprazole enteric-coated tablets and ilaprazole sodium for injection a series of bismuth potassium citrate products for gastrointestinal field; leuprorelin acetate microspheres, urofollitropin, and menotropins for injection for assisted reproduction field; fluvoxamine maleate and perospirone hydrochloride tablets for psychiatric... [Read more]

Sector Healthcare
Founded 1985
Employees 9,067
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000513
Full Company Profile

Financial Performance

In 2024, SHE:000513's revenue was 11.81 billion, a decrease of -4.97% compared to the previous year's 12.43 billion. Earnings were 2.06 billion, an increase of 5.50%.

Financial Statements

News

There is no news available yet.